| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1035443875 |
| P356 | DOI | 10.1385/IR:31:3:243 |
| P698 | PubMed publication ID | 15888915 |
| P2093 | author name string | Stefanie N Vogel | |
| Nilofer Qureshi | |||
| Christopher J Papasian | |||
| Asaf A Qureshi | |||
| David C Morrison | |||
| Charles Van Way | |||
| P2860 | cites work | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 |
| Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2 | Q24290990 | ||
| Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 | Q24310398 | ||
| Structure and function of lipopolysaccharide binding protein | Q24324774 | ||
| Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent | Q24613185 | ||
| Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase | Q24645348 | ||
| Innate immune recognition | Q27860721 | ||
| The complete primary structure of mouse 20S proteasomes | Q28141380 | ||
| Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction | Q28205376 | ||
| Identity of tumour necrosis factor and the macrophage-secreted factor cachectin | Q28286678 | ||
| A toll-like receptor that prevents infection by uropathogenic bacteria | Q28504943 | ||
| TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway | Q28505835 | ||
| Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA | Q28513215 | ||
| The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events | Q28594630 | ||
| Regulation of the mevalonate pathway | Q29547763 | ||
| CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein | Q29615189 | ||
| The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B | Q29618194 | ||
| Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways. | Q31973408 | ||
| A phase 2 study of bortezomib in relapsed, refractory myeloma | Q33348702 | ||
| Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes | Q33702208 | ||
| The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation | Q33733316 | ||
| The proteasome activator 11 S REG (PA28) and class I antigen presentation | Q33796158 | ||
| Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide | Q33938936 | ||
| Intracellular targeting of the proteasome | Q33944912 | ||
| The function of the proteasome system in MHC class I antigen processing. | Q34009896 | ||
| Proteasomes in the archaea: from structure to function | Q34019664 | ||
| ??? | Q64770076 | ||
| Proteasome degradation: enter the substrate | Q44628364 | ||
| Purification of beta-hydroxy-beta-methylglutaryl-coenzyme A reductase from yeast | Q44689106 | ||
| Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages | Q47875817 | ||
| Food Restriction Enhances the Proteolytic Capacity of the Aging Rat Liver | Q48939192 | ||
| Cytoplasmic presenilin aggregates in proteasome inhibitor-treated cells | Q49011862 | ||
| Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Q67685401 | ||
| A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptides | Q70195018 | ||
| Liver adenosine triphosphate (ATP) in hypoxia and hemorrhagic shock | Q70456998 | ||
| Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide | Q71120614 | ||
| Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells | Q71973366 | ||
| Release of a macromolecular protein component from human erythrocyte ghosts | Q72045895 | ||
| Cardiac and skeletal muscle metabolic energy stores in hemorrhagic shock | Q72340179 | ||
| The isolation and purification of a macromolecular protein component from the human erythrocyte ghost | Q72530075 | ||
| Changes in adenine nucleotides during hemorrhagic shock and reperfusion | Q73048861 | ||
| New evidence for beneficial effects of statins unrelated to lipid lowering | Q73366268 | ||
| The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation | Q73596405 | ||
| The use of insulin and glucose during resuscitation from hemorrhagic shock increases hepatic ATP | Q74008190 | ||
| Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12 | Q74477183 | ||
| Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway | Q74485172 | ||
| Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57BL/6 ApoE-deficient mice | Q74587821 | ||
| An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro | Q77754902 | ||
| Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis | Q78117684 | ||
| Mammalian Toll-like receptors | Q78699977 | ||
| Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? | Q34214158 | ||
| Caretaker or undertaker? The role of the proteasome in aging | Q34224564 | ||
| Cation-sensitive neutral endopeptidase: isolation and specificity of the bovine pituitary enzyme | Q34269288 | ||
| Proteasome inhibitors: from research tools to drug candidates | Q34341985 | ||
| Proteasomes and proteasome inhibition in the central nervous system | Q34346616 | ||
| Detecting and responding to hypoxia | Q34506939 | ||
| Transferring substrates to the 26S proteasome. | Q35040957 | ||
| Cellular energetics in hemorrhagic shock: restoring adenosine triphosphate to the cells | Q35136467 | ||
| The Toll-IL-1 receptor adaptor family grows to five members. | Q35155932 | ||
| Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS. | Q35551940 | ||
| Hemorrahagic shock: a new look at an old problem | Q35577111 | ||
| Pathogenesis of sepsis: current concepts and emerging therapies | Q35577116 | ||
| TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression | Q35679602 | ||
| Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle | Q35824460 | ||
| The protective action of allopurinol in an experimental model of haemorrhagic shock and reperfusion | Q35887329 | ||
| Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice | Q36352474 | ||
| Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells | Q36370326 | ||
| Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion | Q37353803 | ||
| Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein | Q37383994 | ||
| Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages | Q37510351 | ||
| HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells | Q38358814 | ||
| Kinetic analysis of the individual reductive steps catalyzed by β-hydroxy-β-methylglutaryl-coenzyme A reductase obtained from yeast | Q39111871 | ||
| Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27 | Q39573099 | ||
| Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin). | Q39594721 | ||
| Cachectin: more than a tumor necrosis factor | Q39755392 | ||
| Proteasomes: protein degradation machines of the cell | Q40646488 | ||
| The effects of lovastatin on proteasome activities in highly purified rabbit 20 S proteasome preparations and mouse MC3T3-E1 osteoblastic cells | Q40707999 | ||
| Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells | Q40797218 | ||
| Lovastatin and simvastatin are modulators of the proteasome. | Q40841557 | ||
| The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Q40858049 | ||
| Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells | Q40879729 | ||
| Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation | Q40884666 | ||
| Possible involvement of proteasome inhibition in aging: implications for oxidative stress. | Q40895097 | ||
| Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation | Q40906263 | ||
| Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. | Q40925745 | ||
| Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. | Q41195715 | ||
| The ubiquitin-mediated proteolytic pathway as a therapeutic area | Q41340821 | ||
| Early clinical experience with the novel proteasome inhibitor PS-519. | Q42138557 | ||
| Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. | Q42525527 | ||
| The cellular chamber of doom. | Q43513552 | ||
| Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion | Q43619451 | ||
| Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock | Q44028476 | ||
| Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats | Q44031120 | ||
| Depletion and restoration of tissue ATP in hemorrhagic shock | Q44356614 | ||
| Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia | Q44470430 | ||
| P433 | issue | 3 | |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 243-260 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | The proteasome: a central regulator of inflammation and macrophage function | |
| P478 | volume | 31 |
| Q37151518 | A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model |
| Q36984148 | A critical role for the inducible proteasomal subunits LMP7 and MECL1 in cytokine production by activated murine splenocytes |
| Q45969598 | A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. |
| Q34626385 | A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus |
| Q33744734 | Akt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effects |
| Q37400540 | Anti-inflammatory Effect of Perilla frutescens (L.) Britton var. frutescens Extract in LPS-stimulated RAW 264.7 Macrophages |
| Q39717275 | Chemical proteomics discloses petrosapongiolide M, an antiinflammatory marine sesterterpene, as a proteasome inhibitor. |
| Q34039823 | Cytochalasin B modulates macrophage-mediated inflammatory responses |
| Q47132046 | Defective Protein Catabolism in Atherosclerotic Vascular Inflammation |
| Q34024993 | Differential effects of lactacystin on cytokine production in activated Jurkat cells and murine splenocytes |
| Q35905393 | Down-regulation of Stathmin Is Required for the Phenotypic Changes and Classical Activation of Macrophages |
| Q39538314 | Ethanol extract of Elaeocarpus petiolatus inhibits lipopolysaccharide-induced inflammation in macrophage cells |
| Q38064967 | Fructus Gardenia (Gardenia jasminoides J. Ellis) phytochemistry, pharmacology of cardiovascular, and safety with the perspective of new drugs development |
| Q37788639 | Genetics of childhood-onset inflammatory bowel disease |
| Q54472829 | Genome-wide transcriptional profiling of mononuclear phagocytes recruited to mouse lungs in response to alveolar challenge with the TLR2 agonist Pam3CSK4. |
| Q34534191 | HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo |
| Q36790665 | Impairment of the ubiquitin-proteasome pathway in RPE alters the expression of inflammation related genes |
| Q34805596 | Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environment |
| Q41612495 | Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice |
| Q64985159 | Inhibition of Proteasome Activity Upregulates IL-6 Expression in RPE Cells through the Activation of P38 MAPKs. |
| Q36086859 | Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor |
| Q35704170 | Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin |
| Q41302166 | Interaction of Proteasomes and Complement C3, Assay of Antisecretory Factor in Blood |
| Q39566694 | LPS-induced formation of immunoproteasomes: TNF-α and nitric oxide production are regulated by altered composition of proteasome-active sites |
| Q38496963 | Lipid A-Mediated Tolerance and Cancer Therapy |
| Q37098578 | Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells |
| Q40009131 | MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-kappaB and activator protein-1. |
| Q34703669 | Multi-omic data integration links deleted in breast cancer 1 (DBC1) degradation to chromatin remodeling in inflammatory response |
| Q35941896 | Nicotinic acetylcholine receptor agonists attenuate septic acute kidney injury in mice by suppressing inflammation and proteasome activity |
| Q37364057 | Nutritional Supplement-5 with a Combination of Proteasome Inhibitors (Resveratrol, Quercetin, δ-Tocotrienol) Modulate Age-Associated Biomarkers and Cardiovascular Lipid Parameters in Human Subjects |
| Q53720678 | Of Mice and Men: Proteasome's Role in LPS-Induced Inflammation and Tolerance. |
| Q39978747 | Oxidative inactivation of the proteasome in retinal pigment epithelial cells. A potential link between oxidative stress and up-regulation of interleukin-8. |
| Q34048268 | Proteasomal degradation of O-GlcNAc transferase elevates hypoxia-induced vascular endothelial inflammatory response†. |
| Q37422527 | Proteasome inactivation promotes p38 mitogen-activated protein kinase-dependent phosphatidylinositol 3-kinase activation and increases interleukin-8 production in retinal pigment epithelial cells |
| Q36301130 | Proteasome protease mediated regulation of cytokine induction and inflammation |
| Q39562508 | Psoralenquinones as a novel class of proteasome inhibitors: design, synthesis and biological evaluation. |
| Q90225030 | Role of Zinc in Immune System and Anti-Cancer Defense Mechanisms |
| Q33679929 | Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease |
| Q35820457 | Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition |
| Q35505150 | Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models |
| Q35539348 | The immunoproteasomes regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages |
| Q36469148 | The pivotal role of TBK1 in inflammatory responses mediated by macrophages |
| Q34143900 | The proteasome regulates bacterial CpG DNA-induced signaling pathways in murine macrophages |
| Q37868923 | The role of immunity in Huntington's disease |
| Q40080281 | The role of the immunoproteasome in interferon-γ-mediated microglial activation |
| Q34468200 | Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice |
| Q90382694 | δ-Tocotrienol feeding modulates gene expression of EIF2, mTOR, protein ubiquitination through multiple-signaling pathways in chronic hepatitis C patients |
Search more.